Hematology/Oncology · Fountain Valley, CA
NPI
1578566998
Since 2005
Specialty
Hematology/Oncology
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
11180 Warner Ave, Ste 351
Fountain Valley, CA, 92708
Phone (714) 698-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
64,257 services
Medicare patients, 2024
177
Average age 73
Drug cost, 2024
$2.8M
1,208 prescriptions
Company payments, 2025
$12K
From 55 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Haresh S Jhangiani was code J0897 (injection, denosumab, 1 mg), 1,442 times for 14 patients. In total Haresh S Jhangiani billed 64,257 services in 87 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,442 | 14 | $20.73 | $30K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,384 | 18 | $0.09 | $124 |
| 99214 Office E&M - Established | Office | 497 | 163 | $96.83 | $48K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 181 | 27 | $4.77 | $864 |
| 96367 Intravenous Infusion, Hydration | Office | 178 | 18 | $25.33 | $4,508 |
| 96413 Chemotherapy Administration | Office | 177 | 21 | $110.01 | $19K |
| 96372 Injection Administration | Office | 161 | 25 | $12.21 | $1,966 |
| 36415 Venipuncture Blood Collection | Office | 143 | 60 | $8.62 | $1,232 |
| 96127 Behavioral Health Services | Office | 115 | 110 | $4.00 | $460 |
| 99215 Office E&M - Established | Office | 108 | 53 | $150.21 | $16K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 91 | 15 | $0.62 | $56.43 |
| 96415 Chemotherapy Administration | Office | 76 | 11 | $24.44 | $1,858 |
| 96365 Intravenous Infusion, Hydration | Office | 54 | 35 | $49.05 | $2,649 |
By year: 2022 $1.3M for 66,216 services; 2023 $1.1M for 52,158 services; 2024 $1.5M for 64,257 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 143 | 60 | $8.62 | $1,232 |
Medicare prescription drug claims, 2024
In 2024, the drug Haresh S Jhangiani prescribed most often to Medicare patients was Letrozole, with 101 prescriptions and refills. In total Haresh S Jhangiani wrote 1,208 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 101 | 219 | 28 | $2,124 |
| Zarxio Filgrastim-Sndz | 53 | 53 | Under 11 | $68K |
| Dexamethasone Sodium Phosphate Generic | 50 | 51 | 12 | $192 |
| Lupron Depot Leuprolide Acetate | 40 | 103 | 17 | $201K |
| Ondansetron Hcl Ondansetron Hcl/Pf | 39 | 40 | Under 11 | $93.02 |
| Diphenhydramine Hcl Generic | 37 | 38 | 11 | $82.52 |
| Fosaprepitant Dimeglumine Generic | 37 | 37 | Under 11 | $3,800 |
| Famotidine Famotidine/Pf | 32 | 32 | Under 11 | $48.47 |
| Xtandi Enzalutamide | 32 | 32 | Under 11 | $444K |
| Levothyroxine Sodium Generic | 27 | 58 | 13 | $240 |
| Atorvastatin Calcium Generic | 24 | 50 | Under 11 | $160 |
| Dexamethasone Generic | 22 | 22 | 13 | $273 |
| Paclitaxel Generic | 22 | 23 | Under 11 | $2,346 |
| Enhertu Fam-Trastuzumab Deruxtecn-Nxki | 21 | 21 | Under 11 | $224K |
| Carboplatin Generic | 20 | 21 | Under 11 | $1,162 |
Brand drugs: - claims; generic drugs: 821 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Haresh S Jhangiani $12K ($12K in general payments such as food, travel and fees) from 55 companies. The largest payer was Stemline Therapeutics Inc. with $7,444.
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 13 | $7,444 |
| Janssen Biotech, Inc. JNJ | 17 | $389 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $341 |
| Celgene Corporation BMY | 15 | $295 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $274 |
| GlaxoSmithKline, LLC. GSK | 16 | $269 |
| Merck Sharp & Dohme LLC MRK | 9 | $244 |
| Abbvie Inc. ABBV | 15 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $185 |
| Genzyme Corporation SNY | 6 | $183 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.